DNA methylation biomarker candidates for early detection of colon cancer

Tumor Biology

Volumn 33, Issue 2, 2012, Pages 363-372

  Yi, Joo Mi ^a   Dhir, Mashaal ^b   Guzzetta, Angela A ^b   Iacobuzio Donahue, Christine A ^b   Heo, Kyu ^a   Yang, Kwang Mo ^a   Suzuki, Hiromu ^c   Toyota, Minoru ^c   Kim, Hwan Mook ^d   Ahuja, Nita ^b  

^a Dongnam Institute of Radiological and Medical Science   (South Korea)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d Gachon University College of Medicine   (South Korea)

Author keywords

Biomarker; Colorectal Cancer (CRC); DNA hypermethylation; Early detection; FBN2; TCERGIL

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; DNA; FIBRILLIN 2; REGULATOR PROTEIN; TRANSCRIPTION ELONGATION REGULATOR 1 LIKE PROTEIN; UNCLASSIFIED DRUG; PRIMER DNA; TUMOR MARKER;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; DNA METHYLATION; DOWN REGULATION; EARLY DIAGNOSIS; EPIGENETICS; FEMALE; FIBRILLIN 2 GENE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSCRIPTION ELONGATION REGULATOR 1 LIKE GENE; COLON TUMOR; CPG ISLAND; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; TUMOR CELL LINE;

AGED; CELL LINE, TUMOR; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84860266396     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0302-2     Document Type: Article

References (34)

1. Jemal ASR, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225-49.
2. Heresbach DMS, D'halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006;18:427-33.
3. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers & Prevention. 2006;15:389-94.
4. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042-54.
5. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-92.
6. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Dong Chen W, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004;36:417-22.
7. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, et al. Gata-4 and gata-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol. 2003;23:8429-39.
8. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of tfpi2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009;69:4691-9.
9. Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genetics. 2007;3:1709-23.
10. Karpf AR JD. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Oncogene. 2002;21:5496-503.
11. Yang Q, Ota K, Tian Y, Kumar A, Wada J, Kashihara N, et al. Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung. Dev Biol. 1999;212:229-42.
12. Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S, et al. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene. 2004;23:8705-10.
13. Sune C, Hayashi T, Liu Y, Lane WS, Young RA, Garcia-BlancoMA. Ca150, a nuclear protein associated with the RNA polymerase ii holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol Cell Biol. 1997;17:6029-39.
14. Sanchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Sune C. Human transcription elongation factor ca150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol Cell Biol. 2006;26:4998-5014.
15. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3B cooperate to silence genes in human cancer cells. Nature. 2002;416:552-6.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821-6.
17. Rhodes DR YJ, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, et al. Oncomine: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1-6.
18. Kaiser SPY, Franklin JL,Halberg RB, YuM, JessenWJ, Freudenberg J, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007;8:R131.
19. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai J, et al. Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage b and c colorectal cancer. Clin Cancer Res. 2009;15:7642-51.
20. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138:958-68.
21. Watanabe T, Kobunai T, Toda E, Yamamoto Y, Kanazawa T, Kazama Y, et al. Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res. 2006;66:9804-8.
22. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457-63.
23. Chan TA GS, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 2008;5:0823-38.
24. Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, Glockner SC, et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res. 2011;17:1535-45.
25. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007;16:R50-9.
26. ZhangW, Glockner SC, Guo M, Machida EO, Wang DH, Easwaran H, et al. Epigenetic inactivation of the canonicalWnt antagonist SRYbox containing gene 17 in colorectal cancer. Cancer Research. 2008;68:2764-72.
27. Tsunoda SSE, De Young NJ, Wang X, Tian ZQ, Liu JF, Jamieson GG, et al. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. Oncological Report. 2009;21:1067-73.
28. Cortese R, Hartmann O, Berlin K, Eckhardt F. Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. Int J Biochem Cell Biol. 2008;40:1494-508.
29. Chen H, Suzuki M, Nakamura Y, Ohira M, Ando S, Iida T, et al. Aberrant methylation of FBN2 in human non-small cell lung cancer. Lung Cancer. 2005;50:43-9.
30. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3:253-66.
31. Lofton-Day C, Model F, DeVos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54:414-23.
32. Kim MS LJ, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Review. 2010;29:181-206.
33. Melotte VLM, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, et al. N-Myc downstream-regulated gene 4 (NDGR4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Canc Inst. 2009;101:916-27.
34. Melotte V, Lentjes MHFM, van den Bosch SM, Hellebrekers DMEI, de Hoon JPJ, Wouters KAD, et al. N-Myc downstreamregulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J National Cancer Institute. 2009;101:916-27.